Takuya Matsushita Selected Research

Takuya Matsushita Research Topics

Disease

34	Multiple Sclerosis 02/2023 - 06/2009
15	Neuromyelitis Optica (Devic's Disease) 01/2021 - 06/2009
12	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 11/2011
7	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 11/2020 - 08/2013
5	Disease Progression 03/2024 - 05/2010
5	Polyneuropathies (Polyneuropathy) 11/2020 - 10/2015
5	Myelitis 11/2016 - 05/2012
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021 - 05/2010
4	Inflammation (Inflammations) 05/2021 - 07/2011
4	Guillain-Barre Syndrome 10/2015 - 07/2011
3	Multiple System Atrophy 01/2023 - 01/2017
3	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2021 - 05/2010
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 12/2009
3	Neuralgia (Stump Neuralgia) 01/2020 - 11/2016
2	Relapsing-Remitting Multiple Sclerosis 01/2023 - 01/2013
2	Neuroinflammatory Diseases 05/2021 - 01/2020
2	Hypertrophy 11/2020 - 10/2015
2	Pain (Aches) 01/2020 - 01/2018
2	Meningitis 01/2019 - 01/2019
2	Ataxia (Dyssynergia) 01/2018 - 11/2016
2	Infections 01/2014 - 01/2013
1	Spinal Cord Diseases 03/2024
1	T-Cell Leukemia (Leukemia, T Cell) 03/2024
1	Gliosis 01/2023
1	Optic Neuritis (Retrobulbar Neuritis) 12/2021
1	Paratuberculosis (Johne's Disease) 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 05/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 12/2020
1	Transverse Myelitis (Necrotizing Myelitis) 11/2020
1	Fatigue 01/2020
1	Trigeminal Nerve Diseases (Trigeminal Nerve Disorders) 01/2020
1	Cognitive Dysfunction 01/2020

Drug/Important Bio-Agent (IBA)

15	Immunoglobulin G (IgG)IBA 11/2021 - 06/2009
11	AntibodiesIBA 01/2021 - 11/2012
8	HLA-DRB1 Chains (HLA DRB1)IBA 12/2021 - 01/2013
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2009
6	Connexin 43 (Connexin43)IBA 01/2023 - 11/2011
5	CytokinesIBA 11/2019 - 05/2010
5	ChemokinesIBA 11/2019 - 05/2010
4	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 10/2012
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 07/2014
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019 - 05/2010
4	AntigensIBA 01/2018 - 01/2013
4	EnzymesIBA 07/2016 - 10/2010
3	Fingolimod Hydrochloride (FTY720)FDA Link 02/2023 - 01/2014
3	ConnexinsIBA 01/2023 - 06/2012
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 01/2016
3	Glial Fibrillary Acidic ProteinIBA 01/2023 - 06/2012
3	HLA-DRB1*04 antigenIBA 12/2021 - 01/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 11/2016
3	AutoantibodiesIBA 01/2021 - 01/2018
3	Oligoclonal BandsIBA 08/2015 - 05/2012
3	ImmunosorbentsIBA 05/2013 - 10/2010
3	Interferon-betaIBA 11/2011 - 11/2009
2	Myelin-Associated GlycoproteinIBA 01/2023 - 11/2020
2	Peptides (Polypeptides)IBA 11/2021 - 01/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2018
2	LectinsIBA 01/2020 - 01/2018
2	plexinIBA 01/2020 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 11/2019 - 01/2017
2	Aquaporin 4IBA 10/2019 - 01/2013
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2013
2	Superoxide Dismutase-1IBA 01/2018 - 04/2012
2	HLA-DPB1 antigen (HLA DPB1)IBA 01/2013 - 10/2012
1	mogamulizumabIBA 03/2024
1	NeopterinIBA 03/2024
1	Dimethyl FumarateIBA 02/2023
1	SynucleinsIBA 01/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2023
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023
1	Lipocalin-2IBA 01/2023
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2023
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2023
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	CC ChemokinesIBA 12/2021
1	Mutant Proteins (Protein, Mutant)IBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 05/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 05/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	EpitopesIBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	TensinsIBA 01/2021
1	CalciumIBA 11/2020
1	PotassiumIBA 11/2020
1	2'-carbomethoxyphenyl 4-guanidinobenzoateIBA 11/2020
1	Antinuclear AntibodiesIBA 02/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020
1	connexin 47IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2019
1	Interleukin-13IBA 11/2019
1	Interleukin-4 (Interleukin 4)IBA 11/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2019
1	Chemokine CCL5IBA 11/2019

Therapy/Procedure

6	Therapeutics 05/2021 - 11/2009
2	Immunotherapy 11/2019 - 01/2018